{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Drug+Carrier&page=2", "query": { "intervention": "Drug Carrier", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Drug+Carrier&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T13:28:01.317Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06074315", "title": "Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Distal Lateral Subungual Onychomycosis", "Onychomycosis" ], "interventions": [ { "name": "Nail Genesis DLSO Product", "type": "DEVICE" }, { "name": "Nail Genesis DLSO Product (vehicle only)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Nail Genesis LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 338, "start_date": "2023-10-01", "completion_date": "2025-01", "has_results": false, "last_update_posted_date": "2023-12-08", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 10, "location_summary": "Fayetteville, Arkansas • Montclair, California • Sacramento, California + 7 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Montclair", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Bernardino", "state": "California" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06074315" }, { "nct_id": "NCT01582880", "title": "Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chemical Injuries", "Unspecified Complication of Corneal Transplant", "Autoimmune Diseases", "Ocular Cicatricial Pemphigoid", "Stevens Johnson Syndrome", "Lupus Erythematosus, Systemic", "Rheumatoid Arthritis", "Other Autoimmune Diseases" ], "interventions": [ { "name": "Riboflavin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joseph B. Ciolino, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2012-03", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2019-10-21", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01582880" }, { "nct_id": "NCT06378359", "title": "Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Staphylococcus Aureus Colonization", "Surgical Site Infections", "Healthcare Associated Infections" ], "interventions": [ { "name": "Screening and decolonization for SA carriers with the 3 drug bundle", "type": "OTHER" }, { "name": "No screening for SA", "type": "OTHER" }, { "name": "no screening", "type": "OTHER" }, { "name": "Nasal povidone-iodine on surgery day plus 2 CHG pre-op showers without screening.", "type": "OTHER" }, { "name": "Nasal alcohol gel on surgery day plus 2 CHG pre-op showers without screening", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2024-01-29", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06378359" }, { "nct_id": "NCT05620043", "title": "Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gene Expression" ], "interventions": [ { "name": "Sculptra", "type": "DEVICE" }, { "name": "Radiesse Plus", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "22 Years to 50 Years" }, "enrollment_count": 21, "start_date": "2022-09-28", "completion_date": "2023-11-06", "has_results": true, "last_update_posted_date": "2026-04-15", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05620043" }, { "nct_id": "NCT03161678", "title": "CES1 Crossover Trial of Clopidogrel and Ticagrelor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Myocardial Infarction", "Thrombosis", "Platelet Dysfunction" ], "interventions": [ { "name": "Clopidogrel", "type": "DRUG" }, { "name": "Ticagrelor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 111, "start_date": "2017-08-22", "completion_date": "2022-12-12", "has_results": true, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Lancaster, Pennsylvania", "locations": [ { "city": "Lancaster", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03161678" }, { "nct_id": "NCT07225998", "title": "Oral N-acetylglucosamine in Crohn's Disease", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohns Disease" ], "interventions": [ { "name": "N-Acetylglucosamine (GlcNAc)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 40, "start_date": "2026-11-01", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07225998" }, { "nct_id": "NCT07434986", "title": "Overnight TI in TLE", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Temporal Lobe Epilepsy (TLE)", "Drug Resistant Epilepsy", "Sleep" ], "interventions": [ { "name": "Non-invasive Temporal Interference (TI) Stimulation Targeting Bilateral Hippocampi", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 20, "start_date": "2026-06-01", "completion_date": "2026-10-30", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07434986" }, { "nct_id": "NCT05564390", "title": "MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm", "Acute Myeloid Leukemia Post Cytotoxic Therapy", "Acute Myeloid Leukemia, Myelodysplasia-Related", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Azacitidine", "type": "DRUG" }, { "name": "Best Practice", "type": "OTHER" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Chest Radiography", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Daunorubicin Hydrochloride", "type": "DRUG" }, { "name": "Decitabine and Cedazuridine", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Emavusertib", "type": "BIOLOGICAL" }, { "name": "Enasidenib", "type": "DRUG" }, { "name": "Epoetin Alfa", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Gemtuzumab Ozogamicin", "type": "DRUG" }, { "name": "Gilteritinib", "type": "DRUG" }, { "name": "Liposome-encapsulated Daunorubicin-Cytarabine", "type": "DRUG" }, { "name": "Luspatercept", "type": "BIOLOGICAL" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Mutation Carrier Screening", "type": "PROCEDURE" }, { "name": "Olutasidenib", "type": "DRUG" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "BIOLOGICAL", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2024-06-18", "completion_date": "2029-05-15", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 337, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 260 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05564390" }, { "nct_id": "NCT01757860", "title": "Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Drug Safety", "Heart; Disease, Activity" ], "interventions": [ { "name": "CARD-024", "type": "DRUG" }, { "name": "Drug Carrier", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Cardiavent Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 34, "start_date": "2011-09", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2012-12-31", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 1, "location_summary": "Kalamazoo, Michigan", "locations": [ { "city": "Kalamazoo", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01757860" }, { "nct_id": "NCT00041808", "title": "Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastases, Neoplasm", "Colorectal Neoplasms", "Esophageal Neoplasms", "Stomach Neoplasms", "Pancreatic Neoplasms", "Breast Neoplasms", "Melanoma", "Sarcoma", "Gastrointestinal Neoplasms", "Lung Neoplasms", "Liver Neoplasms", "Cholangiocarcinoma" ], "interventions": [ { "name": "MTC-DOX for Injection", "type": "DRUG" }, { "name": "Chemotherapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "FeRx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2001-07", "completion_date": "2003-04", "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-09-27T13:28:01.317Z", "location_count": 3, "location_summary": "San Diego, California • San Francisco, California • Temple, Texas", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Temple", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00041808" } ] }